ITGDF (Integral Diagnostics) Total Equity: $452.9 Mil (As of Dec. 2025)


ITGDF Integral Diagnostics Ltd ITGDF
75 GF Score
Price $1.00
GF Value $1.39
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Total Equity?

Integral Diagnostics ITGDF -52.38% 75 Total Equity is $452.9 Mil as of Dec. 2025. GuruFocus rates ITGDF with a GF Score™ of 75/100 and a GF Value™ of $1.39. The stock has 9 warning signs investors should review.

Integral Diagnostics's total equity for the quarter that ended in Dec. 2025 was $452.9 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Integral Diagnostics Total Equity Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integral Diagnostics Total Equity Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 194.76 244.02 250.37 200.34 451.79

Integral Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 201.05 200.34 439.00 451.79 452.93
ITGDF
75GF Score
Integral Diagnostics Ltd ITGDF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integral Diagnostics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Integral Diagnostics's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=928.691-476.906
=451.8

Integral Diagnostics's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=945.996-493.064
=452.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $452.9 Mil mean?
Integral Diagnostics (ITGDF) has a Total Equity of $452.9 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Integral Diagnostics and its competitors.
Is Integral Diagnostics' Total Equity too high?
Integral Diagnostics' current Total Equity is $452.9 Mil. Overall, Integral Diagnostics has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Total Equity compare to TMO and DHR?
Integral Diagnostics' Total Equity of $452.9 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Integral Diagnostics and its competitors. Integral Diagnostics's current Total Equity is $452.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Integral Diagnostics (ITGDF) has a current Total Equity of $452.9 Mil. The stock's GF Value™ is $1.39, compared to a current price of $1.00 — trading 28.1% below its estimated fair value. The current Total Equity is $452.9 Mil. Integral Diagnostics' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Integral Diagnostics (ITGDF), the current Total Equity is $452.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ITGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of $1.00 is trading 28.1% below its estimated GF Value™ of $1.39.

Key valuation signals for ITGDF:

  • Total Equity: $452.9 Mil
  • GF Value™: $1.39 vs. price of $1.00 (28.1% below fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the ITGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integral Diagnostics Business Description

Other Exchanges IDX:Australia
Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
75GF Score

Get the complete analysis for ITGDF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.00
Price
$1.39
GF Value